Menu

Blog

Sep 27, 2023

Nanopore sequencing and DNA barcoding method gives hope of personalized medicine

Posted by in category: biotech/medical

With the ability to map dozens of biomarkers at once, a new method could transform testing for conditions including heart disease and cancer.

Currently, many diseases are diagnosed from blood tests that look for one (such as a protein or other small molecule) or, at most, a couple of biomarkers of the same type.

The new method, developed by scientists at Imperial College London in a research collaboration with Oxford Nanopore Technologies (Oxford Nanopore), can analyze dozens of biomarkers of different types at the same time. This would potentially allow clinicians to gather more information about a patient’s disease.

Comments are closed.